ACC
The cardiology world will come together for an unforgettable educational experience at ACC.25 at the McCormick Place Convention Center in Chicago, IL, March 29 – 31, 2025. At ACC.25, you'll have the opportunity engage with peers from around the globe and learn the latest updates in the field with a focus on transforming cardiovascular care for all!
Conference Highlights
Expert Interviews
Featured
After the CLEAR Outcomes Trial, ASCVD Risk Reduction Remains a Global Challenge, PI Nissen Says
Grace Halsey
April 22 2024
Bempedoic Acid Should be In Everyone's CVD Prevention Toolbox, According to Steven Nissen, MD
Grace Halsey
April 20 2024
Steven Nissen, MD, Discusses the "Sweet Spot" for Bempedoic Acid Among Non-Statin Therapies
Grace Halsey
April 19 2024
Individuals with CVD Consume More Daily Sodium than Recommended, According to New Data
Sydney Jennings
April 9 2024
The Inclisiran Impact on PCSK9: A Primary Care Primer
Grace Halsey
April 8 2024
Michael J Koren, MD, Reviews Success of "Inclisiran First" Strategy and Implications for Clinical Practice
Grace Halsey
April 8 2024
"Inclisiran First" Strategy Leads to 60% Reduction in LDL-C vs 7% for Usual Care: VICTORION-INITIATE Findings
Grace Halsey
April 6 2024
Vaping Associated with Increased Risk of Heart Failure, According to New Research
Sydney Jennings
April 2 2024
CAC Progression in Postmenopausal Women Found Double that of Men in New Research
Grace Halsey
April 2 2024
Young Adults Prescribed ADHD Stimulants May Face Higher Risk of Cardiomyopathy
Sydney Jennings
April 1 2024
Icosapent Ethyl Reduces MACE Across Range of Baseline Lp(a): REDUCE-IT Analysis
Grace Halsey
March 29 2024
Bempedoic Acid Associated with Reduced CV Risk in Statin-Intolerant Individuals Regardless of Ethnicity
Sydney Jennings
March 26 2024
Steven Nissen, MD, Discusses Historic Bempedoic Acid Labeling for CV Risk Reduction
Grace Halsey
March 26 2024
New Data Shed Light on Disparities in Coronary Artery Calcium Screening
Sydney Jennings
March 25 2024
Remotely Delivered Lipid Lowering Program Results in Sustained Target LDL-C Levels in High-Risk Population
Grace Halsey
March 25 2024
Electronic “Nudges” Linking Flu Vaccination to Potential CV Benefits Boosted Uptake in Older Adults in Denmark
Sydney Jennings
March 9 2023
Ketogenic Diet Associated with Increased Serum Lipids, 2-fold Greater Risk of MACE
Grace Halsey
March 8 2023
Bempedoic Acid May be Effective Alternative for Statin-intolerant Patients, According to Data from CLEAR Outcomes Trial
Sydney Jennings
March 7 2023
Likelihood of Optimal GDMT for Patients with T2D, ASCVD Increased with Multifaceted Clinic Intervention
Grace Halsey
March 7 2023
Mediterranean Diet Beneficial for Prevention of Heart Disease, Death in Women
Sydney Jennings
March 3 2023
Advocate for Hypertension Control and Weight Loss to Patients with Obesity, Suggest Authors of New Study
Sydney Jennings
March 1 2023
Lifelong Bachelor Status Significant Predictor of Death in Men, Not Women, with Heart Failure
Sydney Jennings
February 28 2023
Insomnia Associated with Significant Risk for MI, Should be Designated a CV Risk Factor
Grace Halsey
February 28 2023
Cognitive Behavioral Therapy Delivered via Mobile App Reduced HbA1c in Adults with Type 2 Diabetes
Sydney Jennings
February 28 2023
Frequent Cannabis Use Associated with Higher Risk of Coronary Artery Disease
Sydney Jennings
February 24 2023
SuperWIN Retail Nutrition Counseling Study Coauthor Unpacks Findings that Surprised Him
Grace Halsey
April 25 2022
Expanding Reach Beyond Clinic Walls is Essential to the Future of Health Care, says Investigator
Grace Halsey
April 15 2022
SuperWIN Trial of Retail-based Dietary Interventions Wins on Many Levels: Dylan Steen, MD, Explains
Grace Halsey
April 14 2022
Antihypertensive Treatment during Pregnancy Linked to Better Outcomes, According to New NIH Study
April 8 2022
Sotagliflozin Reduced MACE Risk in Patients With and Without Prior CVD, in New Analysis of SCORED Clinical Trial
Sydney Jennings
April 5 2022
